1-4 of 4
Cammie Rinehart
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HER3 Is Required for HER2-Induced Preneoplastic Changes to the Breast Epithelium and Tumor Formation

Free
David B. Vaught, Jamie C. Stanford, Christian Young, Donna J. Hicks, Frank Wheeler, Cammie Rinehart, Violeta Sánchez, John Koland, William J. Muller, Carlos L. Arteaga, Rebecca S. Cook
Journal: Cancer Research
Cancer Res (2012) 72 (10): 2672–2682.
https://doi.org/10.1158/0008-5472.CAN-11-3594
Published: 14 May 2012
View articletitled, HER3 Is Required for HER2-Induced Preneoplastic Changes to the Breast Epithelium and Tumor Formation
Open the PDF for HER3 Is Required for HER2-Induced Preneoplastic Changes to the Breast Epithelium and Tumor Formation in another window
Includes: Supplementary data
Journal Articles

ErbB3 Ablation Impairs PI3K/Akt-Dependent Mammary Tumorigenesis

Free
Rebecca S. Cook, Joan T. Garrett, Violeta Sánchez, Jamie C. Stanford, Christian Young, Anindita Chakrabarty, Cammie Rinehart, Yixian Zhang, Yaming Wu, Lee Greenberger, Ivan D. Horak, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2011) 71 (11): 3941–3951.
https://doi.org/10.1158/0008-5472.CAN-10-3775
Published: 31 May 2011
View articletitled, ErbB3 Ablation Impairs PI3K/Akt-Dependent Mammary Tumorigenesis
Open the PDF for ErbB3 Ablation Impairs PI3K/Akt-Dependent Mammary Tumorigenesis in another window
Includes: Supplementary data
Journal Articles

Abstract 231: Upregulation of HER3 (ErbB3) levels and function counteracts the antitumor effect of HER2 and PI3K inhibitors

Free
Joan Garrett, Cammie Rinehart, Anindita Chakrabarty, Bhuvanesh Dave, William Pao, Charles Manning, Jenny Chang, Carlos Arteaga
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 231.
https://doi.org/10.1158/1538-7445.AM2011-231
Published: 15 April 2011
View articletitled, Abstract 231: Upregulation of HER3 (ErbB3) levels and function counteracts the antitumor effect of HER2 and PI3K inhibitors
Journal Articles

Smad3 suppresses Nrf2-mediated expression of GCLC.

Free
Andrei V. Bakin, Konjeti R. Sekhar, Cammie Rinehart, Michael J. Meredith, Carlos L. Arteaga, Michael L. Freeman
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 806.
Published: 01 April 2004
View articletitled, Smad3 suppresses Nrf2-mediated expression of GCLC.